Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
European Journal of Nuclear Medicine and Molecular Imaging
Literatur
1.
McLuhan M, Fiore Q. The medium is the massage: an inventory of effects. New York: Bantam Books; 1967.
2.
Brant W, Helms C. Fundamentals of diagnostic radiology. Philadelphia: Lippincott Williams & Wilkins; 2007.
3.
Valk PE, Bailey DL, Townsend DW, Maisey MN. Positron emission tomography. Basic science and clinical practice. London: Springer; 2003.
4.
James ML, Gambhir SS. A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev. 2012;92(2):897–965.CrossRefPubMed
5.
Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med. 1993;34:1190–7.
6.
Patton JA, Delbeke D, Sandler MP. Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps. J Nucl Med. 2000;41(8):1364–8.PubMed
7.
Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET/CT tomograph for clinical oncology. J Nucl Med. 2000;41(8):1369–79.PubMed
8.
Schlemmer H, Pichler BJ, Schmand M, Burbar Z, Michel C, Ladebeck R, et al. Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology. 2008;248(3):1028–35.CrossRefPubMed
9.
Bockisch A, Freudenberg LS, Schmidt D, Kuwert T. Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging. Semin Nucl Med. 2009;39(4):276–89.CrossRefPubMed
10.
Beyer T, Veit-Haibach P. State-of-the-art SPECT/CT: technology, methodology and applications-defining a new role for an undervalued multimodality imaging technique. Eur J Nucl Med Mol Imaging. 2014;41(Suppl 1):S1–2.CrossRefPubMed
11.
Bailey D, Pichler BJ, Gückel B, Antoch G, Barthel H, Bhujwalla ZM, et al. Combined PET/MRI: global warming – summary report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany. Mol Imaging Biol. 2018;20(1):4–20.
12.
Townsend D. Multimodality imaging of structure and function. Phys Med Biol. 2008;53(4):R1–R39.CrossRefPubMed
13.
Beyer T, Freudenberg LS, Czernin J, Townsend DW. The future of hybrid imaging – part 3: PET/MR, small-animal imaging and beyond. Insights Imaging. 2011;2(3):235–46.CrossRefPubMedPubMedCentral
14.
Wagner H. Fused image tomography: where do we go from here? J Nucl Med. 1999;40(9):30N–1N.PubMed
15.
Jager P, Slart RH, Corstens F, Oyen WJ, Hoekstra O, Teule J. PET-CT: a matter of opinion? Eur J Nucl Med. 2003;30(3):470–1.CrossRef
16.
Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology. 2002;225(2):575–81.CrossRefPubMed
17.
Kinahan P, Hasegawa B, Beyer T. X-ray based attenuation correction for PET/CT scanners. Semin Nucl Med. 2003;XXXIII(3):166–79.CrossRef
18.
Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys. 1998;25(10):2046–53.CrossRefPubMed
19.
LaCroix KJ, Tsui BM, Hasegawa BH, Brown JK. Investigation of the use of X-ray CT images for attenuation compensation in SPECT. IEEE Trans Nucl Sci. 1994;41:2793–9.CrossRef
20.
Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med. 2004;45(Suppl 1):56S–65S.PubMed
21.
Pfannenberg A, Aschoff P, Brechtel K, Müller M, Klein M, Bares R, et al. Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging. Br J Radiol. 2007;80(954):437–45.CrossRefPubMed
22.
Beyer T, Czernin J, Freudenberg L. Variations in clinical PET/CT operations: results from an international survey among active PET/CT users. J Nucl Med. 2011;52(2):303–10.CrossRefPubMed
23.
Wieder H, Freudenberg LS, Czernin J, Navar BN, Israel O, Beyer T. Variations of clinical SPECT/CT operations: an international survey. Nuklearmedizin. 2012;51(4):154–60.CrossRefPubMed
24.
Wagenknecht G, Kaiser HJ, Mottaghy FM, Herzog H. MRI for attenuation correction in PET: methods and challenges. MAGMA. 2013;26(1):99–113.CrossRefPubMed
25.
Eiber M, Martinez-Möller A, Souvatzoglou M, Holzapfel K, Pickhard A, Löffelbein D, et al. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions. Eur J Nucl Med Mol Imaging. 2011;38(9):1691–701.CrossRefPubMed
26.
Gourtsoyiannis N, McCall I, Reiser M, Silberman B, Bischof Delaloye A, Carrió I, et al. White paper of the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM) on multimodality imaging. Eur Radiol. 2007;17(8):1926–30.CrossRefPubMed
27.
Bischof Delaloye A, Carrió I, Cuocolo A, Knapp W, Gourtsoyiannis N, McCall I, et al. White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging. Eur J Nucl Med Mol Imaging. 2007;34(8):1147–51.CrossRefPubMed
28.
European Association of Nuclear Medicine (EANM); European Society of Radiology (ESR). Multimodality imaging training curriculum – parts II and III. Eur J Nucl Med Mol Imaging. 2012;39(4):557–62.
29.
van Schaik J, Bennink R. Integrated residency in radiology and nuclear medicine in the Netherlands. J Nucl Med. 2017;58(7):9N–11N.PubMed
30.
31.
32.
Bourdieu P, Loïc J. An invitation to reflexive sociology. Chicago: University of Chicago Press; 1992.
33.
Frey KA, Royal HD, Di Carli MF, Dillehay GL, Gordon L, Mankoff DA, et al. ABNM position statement: nuclear medicine professional competency and scope of practice. J Nucl Med. 2011;52(6):994–7.CrossRefPubMed
34.
Delbeke D, Royal HD, Frey KA, Graham MM, Segall GM. SNMMI/ABNM joint position statement on optimizing training in nuclear medicine in the era of hybrid imaging. J Nucl Med. 2012;53(9):1490–4.CrossRefPubMed
35.
Stegger L, Schäfers M, Weckesser M, Schober O. EANM-ESR white paper on multimodality imaging. Eur J Nucl Med Mol Imaging. 2008;35(3):677–80.CrossRefPubMed
36.
Beyer T, Bockisch A, Schober O. 1 + 1 = 3. Nuklearmedizin. 2005;44(Suppl 1):S1.
Metadaten
Titel
Life is not black and white, nor just Shades of Gray
verfasst von
T. Beyer
R. J. Hicks
L. S. Freudenberg
Publikationsdatum
08.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 5/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-018-3943-1

Weitere Artikel der Ausgabe 5/2018

European Journal of Nuclear Medicine and Molecular Imaging 5/2018 Zur Ausgabe

Original Article

Preoperative prediction of microvascular invasion of hepatocellular carcinoma using 18F-FDG PET/CT: a multicenter retrospective cohort study

Original Article

The diagnostic value of 18F–FDG-PET/CT and MRI in suspected vertebral osteomyelitis – a prospective study

Letter to the Editor

Reply to: “All that glitters is not gold – new reconstruction methods using Deauville criteria for patient reporting”

Original Article

Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy

Editorial Commentary

Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma

Image of the Month

Glioblastoma multiforme: another potential application for 68Ga-PSMA PET/CT as a guide for targeted therapy